Drug Database
N02AX06 tapentadol
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Ationdo SR 100mg prolonged release tablets PL 50414/0006
- POM Ationdo SR 150mg prolonged release tablets PL 50414/0007
- POM Ationdo SR 200mg prolonged release tablets PL 50414/0008
- POM Ationdo SR 250mg prolonged release tablets PL 50414/0009
- POM Ationdo SR 25mg prolonged release tablets PL 50414/0004
- POM Ationdo SR 50mg prolonged release tablets PL 50414/0005
- POM Palexia 50mg film coated tablets
- POM Palexia 75 mg film-coated tablets
- POM Palexia Oral Solution 20 mg/ml
- POM Palexia SR 100 mg prolonged-release tablets
- POM Palexia SR 150 mg prolonged-release tablets
- POM Palexia SR 200 mg prolonged-release tablets
- POM Palexia SR 250 mg prolonged-release tablets
- POM Palexia SR 50 mg prolonged-release tablets
- POM Tadomon 100 mg prolonged-release tablets
- POM Tadomon 150 mg prolonged-release tablets
- POM Tadomon 200 mg prolonged-release tablets
- POM Tadomon 250 mg prolonged-release tablets
- POM Tadomon 50 mg prolonged-release tablets
- POM Tapentadol 100mg prolonged-release tablets Aspire Pharma Ltd
- POM Tapentadol Krka 100mg prolonged release tablets
- POM Tapentadol Krka 150 mg prolonged-release tablets
- POM Tapentadol Krka 200 mg prolonged-release tablets
- POM Tapentadol Krka 50 mg prolonged-release tablets
- POM Tapimio 100 mg prolonged-release capsules
- POM Tapimio 150 mg prolonged-release capsules
- POM Tapimio 200 mg prolonged-release capsules
- POM Tapimio 250 mg prolonged-release capsules
- POM Tapimio 50 mg prolonged-release capsules
- POM Vecicom 100 mg Prolonged-release Tablets
- POM Vecicom 150 mg Prolonged-release Tablets
- POM Vecicom 200 mg Prolonged-release Tablets
- POM Vecicom 250 mg Prolonged-release Tablets
- POM Vecicom 50 mg Prolonged-release Tablets
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).